Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up
Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up
复制标题
DOI：
10.1111/j.1600-0447.2006.00842.x
复制
发表时间：
2007-01-01
影响因子：
6.7
通讯作者：
Oldham, J. M.
中科院分区：
文献类型：
--
作者：
Kasen, S.;Cohen, P.;Oldham, J. M.
目的：共病人格障碍（PD）对随后的治疗和精神药物的使用的影响进行了检查，在一个有代表性的样本超过700 individuals.Method：轴I障碍和PD进行了评估，自我和母亲的报告，平均年龄13岁和22岁，并在平均年龄33岁的自我报告。母亲在平均年龄33岁之前报告了参与者的治疗使用;参与者在平均年龄33岁时报告了治疗和精神药物使用。结果如下：同时将患有多个轴I障碍但无PD、轴I障碍-PD合并症和单一疾病的个体与未诊断的个体进行比较。总体而言，随后和过去一年的治疗或精神药物的使用或两者的几率最高时，PD共同发生的情绪，焦虑，破坏性，或物质使用disorder.Conclusion：共同发生的人格病理可能有助于提高精神卫生服务的使用，包括精神药物的使用，在社区中的年轻人。
Objective: The impact of comorbid personality disorder (PD) on subsequent treatment and psychotropic drug use was examined in a representative sample of over 700 individuals.Method: Axis I disorders and PD were assessed by self- and mother-report at mean ages 13 and 22 years, and by self-report at mean age 33. Mothers reported treatment use by participants before mean age 33; participants reported treatment and psychotropic drug use at mean age 33. Results: Individuals with multiple axis I disorders without PD, axis I disorder-PD comorbidity, and single disorders were compared simultaneously to individuals not diagnosed. Overall, odds of subsequent and past year treatment or psychotropic drug use or both were highest when PD co-occurred with a mood, an anxiety, a disruptive, or a substance use disorder.Conclusion: Co-occurring personality pathology may contribute to elevated mental health service use, including use of psychotropic drugs, among young adults in the community.